Rabies virus as vector for development of vaccine: pros and cons.
作者信息
Li Yan, Zhou Houcheng, Li Qian, Duan Xiaoxiao, Liu Fuxiao
机构信息
College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, China.
Qingdao Center for Animal Disease Control and Prevention, Qingdao, China.
出版信息
Front Vet Sci. 2024 Sep 25;11:1475431. doi: 10.3389/fvets.2024.1475431. eCollection 2024.
Abstract
摘要
相似文献
1
Rabies virus as vector for development of vaccine: pros and cons.狂犬病病毒作为疫苗开发载体：利弊分析
Front Vet Sci. 2024 Sep 25;11:1475431. doi: 10.3389/fvets.2024.1475431. eCollection 2024.
2
Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.表达两个拷贝狂犬病病毒糖蛋白基因的磷蛋白缺失狂犬病病毒疫苗载体的免疫调节作用
Vaccine. 2008 Nov 25;26(50):6405-14. doi: 10.1016/j.vaccine.2008.08.069. Epub 2008 Sep 18.
3
Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection.保护性疫苗诱导的针对狂犬病感染的 CD4(+) T 细胞非依赖性 B 细胞应答。
J Virol. 2012 Nov;86(21):11533-40. doi: 10.1128/JVI.00615-12. Epub 2012 Aug 15.
4
A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.一种基于表达狂犬病病毒糖蛋白的重组副流感病毒 5 的新型狂犬病疫苗。
J Virol. 2013 Mar;87(6):2986-93. doi: 10.1128/JVI.02886-12. Epub 2012 Dec 26.
5
Characterization of a single-cycle rabies virus-based vaccine vector.单周期狂犬病病毒疫苗载体的特性。
J Virol. 2010 Mar;84(6):2820-31. doi: 10.1128/JVI.01870-09. Epub 2010 Jan 6.
6
Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.基于重组复制缺陷型狂犬病病毒的二价疫苗（针对 MERS-CoV 和狂犬病病毒）的研制及其在小鼠体内的体液免疫原性。
PLoS One. 2019 Oct 7;14(10):e0223684. doi: 10.1371/journal.pone.0223684. eCollection 2019.
7
A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.基于重组单周期黄病毒载体的狂犬病疫苗新方法。
Vaccine. 2017 Dec 14;35(49 Pt B):6898-6904. doi: 10.1016/j.vaccine.2017.08.055. Epub 2017 Sep 9.
8
Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.基于复制缺陷型狂犬病病毒的疫苗在小鼠和非人灵长类动物中是安全且具有免疫原性的。
J Infect Dis. 2009 Oct 15;200(8):1251-60. doi: 10.1086/605949.
9
Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.基因工程改造的狂犬病病毒载体埃博拉病毒病疫苗在小鼠和犬中安全，并能诱导有效的免疫应答。
Antiviral Res. 2017 Oct;146:36-44. doi: 10.1016/j.antiviral.2017.08.011. Epub 2017 Aug 16.
10
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.一种由稳定的嵌合型和复制缺陷型仙台病毒载体携带的呼吸道合胞病毒疫苗可保护小鼠，且不会引发疾病加重。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02298-16. Print 2017 May 15.
本文引用的文献
1
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.三合一：狂犬病病毒载体表达异源串联 RBD 三聚体的有效且通用疫苗可保护小鼠免受 SARS-CoV-2 感染。
Antiviral Res. 2024 Jul;227:105905. doi: 10.1016/j.antiviral.2024.105905. Epub 2024 May 11.
2
Immunogenicity evaluation of a bivalent vaccine based on a recombinant rabies virus expressing gB protein of FHV-1 in mice and cats.基于表达猫泛白细胞减少症病毒gB蛋白的重组狂犬病病毒的二价疫苗在小鼠和猫中的免疫原性评估
Vet J. 2024 Apr;304:106096. doi: 10.1016/j.tvjl.2024.106096. Epub 2024 Mar 19.
3
Rabies post-exposure prophylaxis in the emergency department.狂犬病的急诊暴露后预防。
Am J Emerg Med. 2024 Apr;78:202-205. doi: 10.1016/j.ajem.2024.01.027. Epub 2024 Jan 29.
4
The Development of a Rabies Virus-Vectored Vaccine against , Targeting BBI39.一种针对BBI39的狂犬病病毒载体疫苗的研发
Vaccines (Basel). 2024 Jan 12;12(1):78. doi: 10.3390/vaccines12010078.
5
An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV.一种嵌合表达 RBD 的灭活重组狂犬病病毒诱导针对 SARS-CoV-2 和 RABV 的体液和细胞免疫。
Virol Sin. 2023 Apr;38(2):244-256. doi: 10.1016/j.virs.2022.12.006. Epub 2022 Dec 29.
6
A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized mice.一种表达两份马尔堡病毒糖蛋白基因的狂犬病病毒载体疫苗可在人源化小鼠中诱导针对马尔堡病毒的中和抗体。
Emerg Microbes Infect. 2023 Dec;12(1):2149351. doi: 10.1080/22221751.2022.2149351.
7
Construction of Recombinant Rabies Virus Vectors Expressing H or F Protein of Peste des Petits Ruminants Virus.表达小反刍兽疫病毒H或F蛋白的重组狂犬病病毒载体的构建
Vet Sci. 2022 Oct 10;9(10):555. doi: 10.3390/vetsci9100555.
8
Rabies Elimination: Is It Feasible without Considering Wildlife?消除狂犬病：不考虑野生动物可行吗？
J Trop Med. 2022 Jun 26;2022:5942693. doi: 10.1155/2022/5942693. eCollection 2022.
9
Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity.灭活狂犬病载体的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗可提供不受载体免疫影响的长期免疫反应。
NPJ Vaccines. 2022 Sep 23;7(1):110. doi: 10.1038/s41541-022-00532-7.
10
A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model.一剂失活狂犬病病毒载体 COVID-19 疫苗 CORAVAX 具有高度疗效，并能减轻仓鼠模型中的肺部炎症。
Viruses. 2022 May 24;14(6):1126. doi: 10.3390/v14061126.
Zotero 插件